NCT00477529 2019-11-22
ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer
Celgene
Phase 1/2 Completed
Clinical Trials
4 trialsNCT00928252 2017-08-14
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Queen's Medical Center
Phase 1/2 Completed
NCT00906243 2012-04-04
RNActive®-Derived Therapeutic Vaccine
University of Florida
Phase 1/2 Terminated
NCT00286806 2010-08-24
A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
Ascenta Therapeutics
Phase 1/2 Completed